Medical Health & Life Science Research News

Discover the cervical cancer vaccine market forecast to 2022

In this report, we analyze the Cervical Cancer Vaccine industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2012 to 2017. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2012 to 2017. We also make a prediction of its production and consumption in coming 2017-2022.

- Advertisement -
- Membership expired -

Download Sample Pages @ www.kminsights.com/request-sample-44849 Make an Inquiry about this news   

Cervical cancer is mainly caused by Human Papilloma Virus (HPV) infection transmitted via sexual contact with an HPV-infected person. Two strains of HPV that are responsible for causing cervical cancer are HPV 16 and HPV 18.

Cervical cancer vaccines are biological preparations that stimulate or strengthen a person's immune system against cancer. Increasing rate of unprotected sex, especially among adolescents, across various developed as well as developing regions, is resulting in growing incidences of cervical cancer, globally.

- Advertisement -
- Membership expired -

Cervical cancer can be prevented via widespread immunization with the HPV vaccine, which prevents infection from high-risk HPV strains and also offers protection against the low-risk ones which cause genital warts. The Center for Disease Control and Prevention (CDC) has recommended that the HPV vaccine be administered to girls and boys falling in the age group of 11 to 12 years old.

Vaccination at an early stage of life, during teenage, is highly effective. In October 2016, the CDC updated the schedule of the HPV vaccination.

It recommends that all teens and adolescents falling between the ages of 9 and 14 should receive two doses of HPV vaccination within a gap of six months.

Download Sample Pages @ www.kminsights.com/request-sample-44849 Make an Inquiry about this news   

The rising rate of cervical cancer among women is of particular concern as it is a significantly common type of cancer and a leading cause of death. Its increasing prevalence worldwide is a major driver for the cervical cancer vaccine market.

The global surge in the number of cervical cancer patients, especially in developing countries, has motivated key players to develop new vaccines at a low cost. Most vaccines for cervical cancer are in their late stage of clinical development.

The rising incidence of cervical cancer has provoked governments and non-profit organizations to take the initiative to create awareness regarding control & prevention of cervical cancer and HPV vaccinations. However, the high cost of the vaccine and the lack of awareness about HPV vaccination in developing countries are major restraining factors for the cervical cancer vaccine market.

The market can be segmented by vaccine type into the bivalent, quadrivalent, and 9-valent varieties. Currently, Gardasil, Gardasil 9, and Cervarix are the only three vaccines approved by the U.S.

FDA and commercially available in market. Gardasil and Gardasil 9 are manufactured by Merck & Co., Inc.

and Cervarix by GlaxoSmithKline plc. Gardasil is a quadrivalent vaccine which targets four different strains of HPV: HPV-6, HPV-11, HPV-16, and HPV-18.Cervarix is a bivalent vaccine targeting only two high-risk strains of HPV: HPV-16 and HPV-18.


Global Cervical Cancer Vaccine Market: Regional Segment Analysis
North America
Europe
China
Japan
Southeast Asia
India

The Major players reported in the market include:
MSD
GSK
company 3
company 4
company 5
company 6
company 7
company 8
company 9
...

Global Cervical Cancer Vaccine Market: Product Segment Analysis
Type I
Type II
Type III

Global Cervical Cancer Vaccine Market: Application Segment Analysis
Application I
Application II
Application III

Reasons for Getting this Report
This report provides pin-point analysis for changing competitive dynamics
It provides a forward looking perspective on different factors driving or restraining market growth
It provides a six-year forecast assessed on the basis of how the market is predicted to grow
It helps in understanding the key product segments and their future
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Download Sample Pages @ www.kminsights.com/request-sample-44849 Make an Inquiry about this news           

News From

Key Market InsightsKey Market Insights
Category: Market Research Publishers and RetailersCompany profile: Key Market Insights is a stand-alone organization with a solid history of advancing and exchanging market research reports and logical surveys delivered by our numerous transnational accomplices, which incorporate both huge multinationals and littler, more expert concerns. Our online stage, KMInsights.com, offers an unmatched gathering of market examination reports, organization audits, databooks, articles, periodical distributions, databases, on-line endorser administrations, and a great deal m ...

For more information:

Make an Inquiry about this report HERE!
  • www.kminsights.com/request-sample-44849
  • tinyurl.com/y8d4numr